Article
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.
Anti-cancer drugs - 1 Aug 2015
Carpi Sara, Fogli Stefano, Romanini Antonella, Pellegrino Mario, Adinolfi Barbara, Podestà Adriano, Costa Barbara, Da Pozzo Eleonora, Martini Claudia, Breschi Maria Cristina, Nieri Paola
Abstract excerpt
Human cutaneous melanoma is an aggressive and chemotherapy-resistant type of cancer. AM251 is a cannabinoid type 1 (CB1) receptor antagonist/inverse agonist with off-target antitumor activity against pancreatic and colon cancer cells. The current study aimed to characterize the in-vitro antimelanoma activity of AM251. The BRAF V600E mutant melanoma cell line, A375, was used as an in-vitro model system....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
